A novel strategy to suppress prostate cancer growth
The researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.
Read more
Search Results for: prostate cancer
Targeting MAPK4 emerges as a promising therapy for prostate cancer
Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read more
New oncogene MNX1 contributes to higher incidence of prostate cancer among African American men
Genetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.
Read more
Prostate cancer: What you need to know
During the month of September, Baylor College of Medicine will be partnering with the Blue Cure Foundation for its annual prostate cancer awareness campaign, Light
Read more
Altered metabolism in castration-resistant prostate cancer may point to new therapies
Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the
Read more
Mouse model shows that Notch activation can drive metastatic prostate cancer
Nearly 200 thousand men are diagnosed with prostate cancer every year. Most of the deaths associated with prostate cancer occur in advanced stages of the
Read more
Baylor College of Medicine lights up blue in honor of Prostate Cancer Awareness Month
September officially kicks off National Prostate Cancer Awareness Month, and in a show of support for increased awareness, education, research and clinical advances, the Baylor
Read more
Coactivator forges pathway for survival of metastatic prostate cancer
By Ruth SoRelle, M.P.H. A steroid receptor coactivator (SRC-2) drives the metabolic mechanism that allows prostate cancer not only to grow but also to spread
Read moreBlocking a coactivator may be answer to androgen-resistant prostate cancer
By Ruth SoRelle, M.P.H. Treating advanced prostate cancer with drugs that block androgens or male hormones can result in resistance to the drugs, and is
Read more
New research supports benefits of bariatric surgery in long-term weight loss and cancer risk reduction
Collaboration between bariatric surgery and and oncology teams identify patients with obesity who may be at a cancer risk.
Read more